BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7876567)

  • 1. Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA.
    Caponi L; Pegoraro S; Di Bartolo V; Rovero P; Revoltella R; Bombardieri S
    J Immunol Methods; 1995 Feb; 179(2):193-202. PubMed ID: 7876567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus.
    Lin JL; Dubljevic V; Fritzler MJ; Toh BH
    Clin Exp Immunol; 2005 Jul; 141(1):155-64. PubMed ID: 15958082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins.
    Fabien N; Moreira A; Lavergne JP; Desbos A; Surgey P; Alves de Olivera C; Gonzalo P; Venot A; Bienvenu J; Perrier H; Reboud JP; Monier JC
    J Autoimmun; 1999 Aug; 13(1):103-10. PubMed ID: 10441174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.
    Tzioufas AG; Tzortzakis NG; Panou-Pomonis E; Boki KA; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Ann Rheum Dis; 2000 Feb; 59(2):99-104. PubMed ID: 10666163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins.
    Mahler M; Kessenbrock K; Raats J; Williams R; Fritzler MJ; Blüthner M
    J Mol Med (Berl); 2003 Mar; 81(3):194-204. PubMed ID: 12682728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic tests for antiribosomal p protein antibodies: a comparative evaluation of immunoblotting and ELISA assays.
    Ghirardello A; Caponi L; Franceschini F; Zampieri S; Quinzanini M; Bendo R; Bombardieri S; Gambari PF; Doria A
    J Autoimmun; 2002; 19(1-2):71-7. PubMed ID: 12367561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus.
    Li J; Shen Y; He J; Jia R; Wang X; Chen X; Wang D; Han L; Zhu L; Chi X; Saschenbrecker S; Dähnrich C; Stöcker W; Schlumberger W; Li ZG
    J Clin Lab Anal; 2013 Mar; 27(2):87-95. PubMed ID: 23400861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system function in systemic lupus erythematosus.
    Elkon K; Weissbach H; Brot N
    Neurochem Res; 1990 Apr; 15(4):401-6. PubMed ID: 1697040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiribosomal antibodies in SLE, infection, and following deliberate immunization.
    Elkon KB; Bonfa E; Weissbach H; Brot N
    Adv Exp Med Biol; 1994; 347():81-92. PubMed ID: 7976736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region.
    Bruner BF; Wynn DM; Reichlin M; Harley JB; James JA
    Ann N Y Acad Sci; 2005 Jun; 1051():390-403. PubMed ID: 16126981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection.
    Kessenbrock K; Fritzler MJ; Groves M; Eissfeller P; von Mühlen CA; Höpfl P; Mahler M
    J Mol Med (Berl); 2007 Sep; 85(9):953-9. PubMed ID: 17668158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients.
    Gerli R; Caponi L; Tincani A; Scorza R; Sabbadini MG; Danieli MG; De Angelis V; Cesarotti M; Piccirilli M; Quartesan R; Moretti P; Cantoni C; Franceschini F; Cavazzana I; Origgi L; Vanoli M; Bozzolo E; Ferrario L; Padovani A; Gambini O; Vanzulli L; Croce D; Bombardieri S
    Rheumatology (Oxford); 2002 Dec; 41(12):1357-66. PubMed ID: 12468814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of epitopes on the SmD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus.
    Sabbatini A; Dolcher MP; Marchini B; Bombardieri S; Migliorini P
    J Rheumatol; 1993 Oct; 20(10):1679-83. PubMed ID: 7507527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus.
    Barkhudarova F; Dähnrich C; Rosemann A; Schneider U; Stöcker W; Burmester GR; Egerer K; Schlumberger W; Hiepe F; Biesen R
    Arthritis Res Ther; 2011 Feb; 13(1):R20. PubMed ID: 21310064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-P autoantibody production requires P1/P2 as immunogens but is not driven by exogenous self-antigen in MRL mice.
    Hines JJ; Weissbach H; Brot N; Elkon K
    J Immunol; 1991 May; 146(10):3386-95. PubMed ID: 2026870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays.
    Agmon-Levin N; Gilburd B; Kivity S; Katz BS; Flitman-Katzevman I; Shoenfeld N; Paran D; Langevitz P; Shoenfeld Y
    Isr Med Assoc J; 2009 Jul; 11(7):403-6. PubMed ID: 19911490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of lupus anti-ribosome P antibodies using a recombinant P2 fusion protein and determination of the predicted amino acid sequence of the autoantigen in patients' mononuclear cells.
    Magsaam J; Gharavi AE; Parnassa AP; Weissbach H; Brot N; Elkon KB
    Clin Exp Immunol; 1989 May; 76(2):165-71. PubMed ID: 2758693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides.
    Heinlen LD; Ritterhouse LL; McClain MT; Keith MP; Neas BR; Harley JB; James JA
    J Mol Med (Berl); 2010 Jul; 88(7):719-27. PubMed ID: 20396862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic benefit of antibodies against ribosomal proteins in systemic lupus erythematosus.
    Shi ZR; Han YF; Yin J; Zhang YP; Jiang ZX; Zheng L; Tan GZ; Wang L
    Adv Rheumatol; 2020 Aug; 60(1):45. PubMed ID: 32859277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
    Hirohata S; Arinuma Y; Takayama M; Yoshio T
    Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.